UNLIMITED Watchlists, Portfolios, Screeners, and other Barchart tools with Barchart Premier. FREE 30 Day Trial
or

Cardio Diagnostics Hldgs Inc (CDIO)

Cardio Diagnostics Hldgs Inc (CDIO)
0.4000 x 50 0.4100 x 200
Post-market by (Cboe BZX)
0.4140 +0.0440 (+11.89%) 04/22/25 [NASDAQ]
0.4000 x 50 0.4100 x 200
Post-market 0.4000 -0.0140 (-3.38%) 19:48 ET
Quote Overview for Tue, Apr 22nd, 2025
Watch
    Add or delete the symbol from one or more Watchlists.
Day Low
0.3700
Day High
0.4200
Open 0.3900
Previous Close 0.3700 0.3700
Volume 609,500 609,500
Avg Vol 755,065 755,065
Stochastic %K 74.35% 74.35%
Weighted Alpha -77.54 -77.54
5-Day Change +0.0215 (+5.53%) +0.0215 (+5.53%)
52-Week Range 0.1900 - 1.7700 0.1900 - 1.7700
  • 1D
  • 5D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
  • MAX
Full Chart
  • OHLC Bars
  • Colored OHLC Bars
  • HLC Bars
  • Candlestick Hollow
  • Candlestick Open-to-Close
  • Candlestick Close-to-Close
  • Heikin-Ashi
  • Line Chart
  • Area Chart
  • Renko
  • Column
  • Baseline
  • Line Break
  • Range
  • Kagi
  • Point And Figure
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 19,294
  • Shares Outstanding, K 52,145
  • Annual Sales, $ 30 K
  • Annual Income, $ -8,380 K
  • EBIT $ -8 M
  • EBITDA $ -8 M
  • 60-Month Beta 3.73
  • Price/Sales 580.90
  • Price/Cash Flow N/A
  • Price/Book 1.65
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -0.32
  • Most Recent Earnings $-0.06 on 11/13/24
  • Next Earnings Date 05/21/25
  • Annual Dividend & Yield N/A (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sector Medical
  • INDUSTRY GROUPING Medical - Biomedical

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 2 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/24
See More
  • Average Estimate N/A
  • Number of Estimates 0
  • High Estimate N/A
  • Low Estimate N/A
  • Prior Year N/A
  • Growth Rate Est. (year over year) unch

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.2800 +46.43%
on 04/07/25
Period Open: 0.4500
0.4700 -12.77%
on 03/24/25
-0.0400 (-8.89%)
since 03/21/25
3-Month
0.2800 +46.43%
on 04/07/25
Period Open: 0.6269
0.6850 -40.15%
on 02/13/25
-0.2169 (-34.60%)
since 01/22/25
52-Week
0.1900 +115.79%
on 10/11/24
Period Open: 0.7490
1.7700 -76.84%
on 12/12/24
-0.3390 (-45.26%)
since 04/22/24

Most Recent Stories

More News
Global Drug Screening Market Is Forecasted to Reach $19.5 Billion By 2029

EQNX::TICKER_START (NASDAQ:INBS),(NASDAQ:CDIO),(NASDAQ:BIAF),(NASDAQ:TRIB),(NASDAQ:SOBR) EQNX::TICKER_END

TRIB : 0.5310 (-4.84%)
BIAF : 0.5100 (+2.70%)
INBS : 1.2400 (+2.48%)
CDIO : 0.4100 (+10.81%)
SOBR : 3.30 (+3.45%)
Top 5 Biotech Stocks Dominating Retail Investor Conversations In 2024

From Tonix Pharmaceuticals’ progress on fibromyalgia treatments to Nvidia-backed Recursion Pharmaceuticals, these stocks sparked significant message volume growth on Stocktwits.

GALT : 1.3300 (+1.53%)
TNXP : 14.96 (unch)
CDIO : 0.4100 (+10.81%)
CADL : 4.74 (+5.10%)
RXRX : 5.63 (+4.07%)
Cardio Diagnostics Holdings, Inc Unveils The CardioInnovate360TM BioPharma Research System

Cardio Diagnostics Holdings, Inc (Nasdaq: CDIO), a precision cardiovascular medicine company, today announced the availability of its CardioInnovate360 TM research-use-only (RUO) solution for biopharmaceutical...

CDIO : 0.4100 (+10.81%)
Juniper Research Awards Cardio Diagnostics Holdings, Inc Future Digital Award for Best Digital Diagnostics Solution

Cardio Diagnostics Holdings, Inc (Nasdaq: CDIO), a precision cardiovascular medicine company, today announced its PrecisionCHD™ test received Juniper Research’s Future Digital Award for the “Best...

CDIO : 0.4100 (+10.81%)
Cardio Diagnostics Holdings, Inc to Attend 22nd Annual AHOU Conference

Cardio Diagnostics Holdings, Inc (NASDAQ: CDIO) today announced that it is participating and exhibiting at the 22 nd Annual Association of Home Office Underwriters (AHOU) Conference, a premier event...

CDIO : 0.4100 (+10.81%)
Cardio Diagnostics Holdings, Inc Announces Strategic Engagement with Lifespan.io to Drive Longevity & Heart Disease Research and Education

Cardio Diagnostics Holdings, Inc (Nasdaq: CDIO), an artificial intelligence-powered precision cardiovascular medicine company, today announced a strategic engagement with Lifespan.io , a leading nonprofit...

CDIO : 0.4100 (+10.81%)
Cardio Diagnostics Holdings, Inc Sponsors Becker’s Hospital Review 13th Annual Meeting

Cardio Diagnostics Holdings, Inc (NASDAQ: CDIO) today announced that it is sponsoring Becker’s Hospital Review 13th Annual Meeting. The conference is taking place next week, April 3-6, 2023, at the...

CDIO : 0.4100 (+10.81%)
Cardio Diagnostics Holdings, Inc Announces Financing Agreement with Yorkville Advisors Global, LP of up to $11.2 Million

Cardio Diagnostics Holdings, Inc (the “Company”) (Nasdaq: CDIO), an artificial intelligence-powered precision cardiovascular medicine company, today announced that it has entered into a securities...

CDIO : 0.4100 (+10.81%)
Cardio Diagnostics Holdings, Inc Welcomes Dr. Damon Broyles, MD, as Strategic Advisor for Precision Cardiovascular Medicine Strategy

Cardio Diagnostics Holdings, Inc (Nasdaq: CDIO), an artificial intelligence-powered precision cardiovascular medicine company, today announced Dr. Damon Broyles, MD, the VP of Clinical Innovation at Mercy...

CDIO : 0.4100 (+10.81%)
Cardio Diagnostics Holdings Inc Announces Expansion of IP Portfolio with Notice of Allowance of Patent Application

Cardio Diagnostics Holdings Inc (Nasdaq: CDIO), an artificial intelligence-powered precision cardiovascular medicine company, today announced that China’s Patent Office has issued a Notice of Allowance...

CDIO : 0.4100 (+10.81%)

Business Summary

Cardio Diagnostics Inc. is a biotechnology company which makes cardiovascular disease prevention and early detection more accessible, personalized and precise. Cardio Diagnostics Inc., formerly known as Mana Capital Acquisition Corp., is based in DOVER, Del.

See More

Key Turning Points

3rd Resistance Point 0.4800
2nd Resistance Point 0.4500
1st Resistance Point 0.4300
Last Price 0.4100
1st Support Level 0.3800
2nd Support Level 0.3500
3rd Support Level 0.3300

See More

52-Week High 1.7700
Fibonacci 61.8% 1.1664
Fibonacci 50% 0.9800
Fibonacci 38.2% 0.7936
Last Price 0.4100
52-Week Low 0.1900

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar
Unlock High-Probability Trade Setups: Master Fractals & Time Frames Like a Pro